Bexarotene is a retinoid used to treat cutaneous T-cell lymphoma by affecting gene expression to control cell proliferation. It is grouped under the following drug class(es): Retinoids. Its therapeutic use is listed as dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Targretin and Targrexin. Its PubChem CID is 82146.
Bexarotene
| CAS No | 153559-49-0 |
|---|---|
| Molecular Formula | C24H28O2 |
| Molecular Weight | 348.5 g/mol |
| Synonyms | 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bexarotene is a retinoid used to treat cutaneous T-cell lymphoma by affecting gene expression to control cell proliferation. It is grouped under the following drug class(es): Retinoids.
The listed CAS number is 153559-49-0.
The listed molecular formula is C24H28O2.
The listed molecular weight is 348.5 g/mol.
4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid.
The source lists Targretin and Targrexin.